AbbVie Inc. — Form 10-Q
Filed August 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Robert A. Michael (CEO) and Scott T. Reents (CFO) certified the June 30, 2026 quarterly report on August 3, 2026. Both officers attested that financial statements fairly present AbbVie's condition and results, that disclosure controls and internal controls over financial reporting are effective, and that no material weaknesses or significant deficiencies in internal controls were identified. No specific operational, financial, or transactional data is provided in these certification exhibits.
Why this rating
Routine SOX 302/906 officer certifications; standard filing requirement with no disclosed control deficiencies or fraud. No business impact.
See more from August 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.